EFFECTIVENESS OF HPV VACCINATION

American Journal of Public Health

Ecological Association of Human Papillomavirus Vaccination With Cervical Dysplasia Prevalence in the United States, 2007–2014

Elaine W. Flagg, PhD, MS; Elizabeth A. Torrone, PhD, MS; Hillard Weinstock, MD, MPH

Disclosures

Am J Public Health. 2016;106(12):2211-2218. 

Abstract and Introduction 

Abstract

Objectives. To examine prevalence of low- and high-grade cervical lesions over time in a large cohort of US female adolescents and women.

Methods. We used health care claims data from 9 million privately insured female patients aged 15 to 39 years to estimate annual prevalence of cytologically detected cervical low-grade (LSIL) and high-grade squamous intraepithelial lesions (HSIL) and high-grade histologically detected cervical intraepithelial neoplasia grades 2 and 3 (CIN2+) during 2007 through 2014. We restricted analyses to those who received cervical cancer screening in a given calendar year.

Results. Prevalence of HSIL and CIN2+ decreased significantly for those aged 15 to 19 years. Average annual percent change in prevalence in this group during 2007 through 2014 for HSIL and CIN2+ was −8.3% and −14.4%, respectively (P < .001 for both estimates). Prevalence of HSIL and CIN2+ also decreased significantly for women aged 20 to 24 years. No decreases were seen in women aged 25 to 39 years.

Conclusions. Decreases in high-grade lesions reflected their greater association with human papillomavirus types 16 and 18, compared with low-grade lesions, providing ecological evidence of population effectiveness of human papillomavirus vaccination among young, privately insured women.